LexisNexis Risk Solutions Risk Defense Platform Achieves NIST 800-63A Certification from SAFE-BioPharma

WASHINGTON and ATLANTA, Dec. 18, 2018

SAFE-BioPharma is a U.S. Trust Framework Provider that certifies technologies and practices used by identity credential issuers. The new certification enables federal agencies to deploy the LexisNexis® Risk Defense Platform suite of identity proofing solutions with confidence that they meet the highest levels of identity fraud protection. NIST 800-63A certification means that the LexisNexis Risk Defense Platform can be trusted and used at known levels of assurance by U.S. federal entities. 

"Federal agencies need more robust identity proofing capabilities to combat the constantly-evolving identity theft and fraud schemes that cost millions of dollars annually," said Haywood Talcove, CEO, Government, LexisNexis Risk Solutions. "With NIST 800-63A certification and the release of  Gartner's Market Guide for Identity Proofing and Corroboration and the inclusion of the Risk Defense Platform, we believe LexisNexis Risk Solutions provides the highest level of protection to help ensure that people who interact with and/or do business with government agencies are securely credentialed and bound to their real-world identities."

The LexisNexis Risk Defense Platform is a full suite of identity proofing solutions that can be accessed through a single system, giving government agencies the flexibility to verify identities and self-reported information. It provides a configurable policy decision engine designed to help government agencies manage complex fraud and identity rules, while reining in the operational resources needed to defend against fraud.

With NIST 800-63A IAL2 identity assurance level certification, the LexisNexis Risk Defense Platform supports a variety of acceptable identity proofing techniques to improve user adoption, decrease false negatives and discern between a real user and a fraudster.

To read Gartner's Market Guide for Identity Proofing and Corroboration, download a complimentary copy at  http://solutions.lexisnexis.com\gartnerguide?trmid=gvhhsv18.hhsdemgen.idmrin.lp-162207&source=NISTPR.